1. Home
  2. IRTC vs CSQ Comparison

IRTC vs CSQ Comparison

Compare IRTC & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRTC
  • CSQ
  • Stock Information
  • Founded
  • IRTC 2006
  • CSQ 2003
  • Country
  • IRTC United States
  • CSQ United States
  • Employees
  • IRTC N/A
  • CSQ N/A
  • Industry
  • IRTC Medical/Dental Instruments
  • CSQ Finance Companies
  • Sector
  • IRTC Health Care
  • CSQ Finance
  • Exchange
  • IRTC Nasdaq
  • CSQ Nasdaq
  • Market Cap
  • IRTC 3.1B
  • CSQ 2.8B
  • IPO Year
  • IRTC 2016
  • CSQ N/A
  • Fundamental
  • Price
  • IRTC $140.65
  • CSQ $17.31
  • Analyst Decision
  • IRTC Strong Buy
  • CSQ
  • Analyst Count
  • IRTC 10
  • CSQ 0
  • Target Price
  • IRTC $135.60
  • CSQ N/A
  • AVG Volume (30 Days)
  • IRTC 595.8K
  • CSQ 220.3K
  • Earning Date
  • IRTC 05-01-2025
  • CSQ 01-01-0001
  • Dividend Yield
  • IRTC N/A
  • CSQ 7.53%
  • EPS Growth
  • IRTC N/A
  • CSQ N/A
  • EPS
  • IRTC N/A
  • CSQ N/A
  • Revenue
  • IRTC $618,587,000.00
  • CSQ N/A
  • Revenue This Year
  • IRTC $19.91
  • CSQ N/A
  • Revenue Next Year
  • IRTC $16.81
  • CSQ N/A
  • P/E Ratio
  • IRTC N/A
  • CSQ N/A
  • Revenue Growth
  • IRTC 20.54
  • CSQ N/A
  • 52 Week Low
  • IRTC $55.92
  • CSQ $12.50
  • 52 Week High
  • IRTC $146.58
  • CSQ $16.45
  • Technical
  • Relative Strength Index (RSI)
  • IRTC 65.78
  • CSQ 61.45
  • Support Level
  • IRTC $137.98
  • CSQ $17.08
  • Resistance Level
  • IRTC $146.58
  • CSQ $17.35
  • Average True Range (ATR)
  • IRTC 3.68
  • CSQ 0.21
  • MACD
  • IRTC -1.20
  • CSQ -0.02
  • Stochastic Oscillator
  • IRTC 33.96
  • CSQ 70.18

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About CSQ Calamos Strategic Total Return

Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.

Share on Social Networks: